Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
2017 · Scientific Reports · 195 citations
https://doi.org/10.1038/s41598-017-15813-8
N
Nour K. Majbour
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
3.0K
Citations
27
h-index
38
i10-index
Nour K. Majbour is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Neurological disorders and treatments & Alzheimer's disease research and treatments. The author has an h-index of 27, co-authored 66 publications.
ORCID: 0000-0002-7544-8497Papers by this author
worksIncreased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
2017 · Scientific Reports · 57 citations
https://doi.org/10.1038/srep40263
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
2021 · Molecular Neurodegeneration · 26 citations
https://doi.org/10.1186/s13024-021-00497-6
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
2018 · Journal of Neuroinflammation · 18 citations
https://doi.org/10.1186/s12974-018-1202-9
PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features
2025 · Journal of Neurology · 1 citations
https://doi.org/10.1007/s00415-025-13022-2
Additional file 2: Figure S2. of A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3629282_d5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat